LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home ...
The long-awaited Canadian approval of lecanemab has shifted physicians’ approach to Alzheimer’s disease, addressing previous ...
The process of TIL therapy is complex and requires the coordination of multiple specialties at authorized treatment centers, ...
Bristol Myers Squibb today announced that the European Commission (EC) has granted approval to Breyanzi® (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell ...
Shockwave’s first-of-its-kind technology is now available on two platforms: a Forward IVL platform and a Balloon IVL platform ...
Infectious meningoencephalitis, characterized by inflammation of both the brain and adjacent meninges, is caused by a variety ...
The firm will initially seek approval in patients who've had prior ALK inhibitors but has ambitions to eventually make neladalkib a first-line option.
The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...
CTE, like Alzheimer’s disease, is associated with a buildup of tau protein in the brain. A blood test measuring the ratios of ...
Scientists are learning how the brain knows what’s happening throughout the body, and how that process might go awry in some ...
“Elevated leukocyte counts, particularly increased neutrophil counts, and decreased hemoglobin levels, are associated with severe WMHs,” according to Dr Liu’s team. “Our study results highlight the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback